These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28936160)

  • 41. Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder.
    Tan XW; Seow E; Abdin E; Verma S; Sim K; Chong SA; Subramaniam M
    BMC Psychiatry; 2019 Sep; 19(1):267. PubMed ID: 31477079
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic mild stress leads to aberrant glucose energy metabolism in depressed Macaca fascicularis models.
    Qin Y; Jiang X; Li W; Li J; Tian T; Zang G; Fang L; Zhou C; Xu B; Gong X; Huang C; Yang X; Bai M; Fan L; Xie P
    Psychoneuroendocrinology; 2019 Sep; 107():59-69. PubMed ID: 31108306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Digging deeper in the proteome of different regions from schizophrenia brains.
    Reis-de-Oliveira G; Zuccoli GS; Fioramonte M; Schimitt A; Falkai P; Almeida V; Martins-de-Souza D
    J Proteomics; 2020 Jul; 223():103814. PubMed ID: 32389842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reductions in cholesterol and synaptic markers in association cortex in mood disorders.
    Beasley CL; Honer WG; Bergmann K; Falkai P; Lütjohann D; Bayer TA
    Bipolar Disord; 2005 Oct; 7(5):449-55. PubMed ID: 16176438
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers.
    Giusti L; Ciregia F; Mazzoni MR; Lucacchini A
    Expert Rev Proteomics; 2016 Oct; 13(10):941-950. PubMed ID: 27568681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains.
    Saia-Cereda VM; Cassoli JS; Schmitt A; Falkai P; Nascimento JM; Martins-de-Souza D
    Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):601-12. PubMed ID: 26232077
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder.
    Bakkour N; Samp J; Akhras K; El Hammi E; Soussi I; Zahra F; Duru G; Kooli A; Toumi M
    Psychiatry Res; 2014 May; 216(3):291-302. PubMed ID: 24656516
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for Borderline Personality Disorder in Psychiatric Outpatients With Major Depressive Disorder and Bipolar Disorder.
    Zimmerman M; Balling C; Dalrymple K; Chelminski I
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677270
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia.
    Whitton AE; Treadway MT; Pizzagalli DA
    Curr Opin Psychiatry; 2015 Jan; 28(1):7-12. PubMed ID: 25415499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: a nationwide population-based study.
    Chen MH; Hsu JW; Huang KL; Su TP; Li CT; Lin WC; Tsai SJ; Cheng CM; Chang WH; Pan TL; Chen TJ; Bai YM
    Psychol Med; 2019 Oct; 49(14):2397-2404. PubMed ID: 30415649
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.
    McOmish CE; Pavey G; Gibbons A; Hopper S; Udawela M; Scarr E; Dean B
    J Affect Disord; 2016 Jan; 190():241-248. PubMed ID: 26521087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Social brain, social dysfunction and social withdrawal.
    Porcelli S; Van Der Wee N; van der Werff S; Aghajani M; Glennon JC; van Heukelum S; Mogavero F; Lobo A; Olivera FJ; Lobo E; Posadas M; Dukart J; Kozak R; Arce E; Ikram A; Vorstman J; Bilderbeck A; Saris I; Kas MJ; Serretti A
    Neurosci Biobehav Rev; 2019 Feb; 97():10-33. PubMed ID: 30244163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.
    Wesseling H; Gottschalk MG; Bahn S
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25539505
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes.
    Beasley CL; Pennington K; Behan A; Wait R; Dunn MJ; Cotter D
    Proteomics; 2006 Jun; 6(11):3414-25. PubMed ID: 16637010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Convergent Lines of Evidence Support LRP8 as a Susceptibility Gene for Psychosis.
    Li M; Huang L; Grigoroiu-Serbanescu M; Bergen SE; Landén M; Hultman CM; Forstner AJ; Strohmaier J; Hecker J; Schulze TG; Müller-Myhsok B; Reif A; Mitchell PB; Martin NG; Cichon S; Nöthen MM; Alkelai A; Lerer B; Jamain S; Leboyer M; Bellivier F; Etain B; Kahn JP; Henry C; Rietschel M; ;
    Mol Neurobiol; 2016 Dec; 53(10):6608-6619. PubMed ID: 26637325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders.
    Gawryluk JW; Wang JF; Andreazza AC; Shao L; Young LT
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):123-30. PubMed ID: 20633320
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial Involvement in Mental Disorders; Energy Metabolism, Genetic, and Environmental Factors.
    Iwata K
    Methods Mol Biol; 2019; 1916():41-48. PubMed ID: 30535680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct proteomic profiles in post-mortem pituitary glands from bipolar disorder and major depressive disorder patients.
    Stelzhammer V; Alsaif M; Chan MK; Rahmoune H; Steeb H; Guest PC; Bahn S
    J Psychiatr Res; 2015 Jan; 60():40-8. PubMed ID: 25455508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism.
    Misra M; Papakostas GI; Klibanski A
    J Clin Psychiatry; 2004 Dec; 65(12):1607-18; quiz 1590, 1760-1. PubMed ID: 15641865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.